← Leaderboards
Claire E O'Leary
University Of Wisconsin-Madison
$548,895
Attributed
$548,895
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $162K · FY2013–25$200K$150K$100K$50K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$548,895 · 3
By mechanism
K22$333,000 · 1
F32$144,436 · 1
F31$71,459 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Anna Huttenlocher$34,294,518
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryPathologyImmuneInflammationCellsHomeostasisDisease ProgressionTissuesInflammatory ResponseLymphoid CellGallbladderImmunoregulationNeutrophilIn VivoExtrahepatic Bile DuctsLinkEpithelial CellsInfiltrationBiliaryAcuteBiliary TractExtrahepaticBiliary Tract DiseasesAdult
Grant awards (8)
Modulation of the biliary immune niche by the microbiome - Administrative supplement$63,000
K22 · FY2025 · AI · contact PI
Modulation of the biliary immune niche by the microbiome$108,000
K22 · FY2024 · AI · contact PI
Modulation of the biliary immune niche by the microbiome$162,000
K22 · FY2023 · AI · contact PI
Development and Function of Biliary Tuft Cells$2,500
F32 · FY2022 · DK · contact PI
Development and Function of Biliary Tuft Cells$72,630
F32 · FY2021 · DK · contact PI
Development and Function of Biliary Tuft Cells$69,306
F32 · FY2020 · DK · contact PI
Ndfip2 limits Th17 pathogenicity to attenuate colitis-associated colon cancer$29,227
F31 · FY2014 · CA · contact PI
Ndfip2 limits Th17 pathogenicity to attenuate colitis-associated colon cancer$42,232
F31 · FY2013 · CA · contact PI